Metabolic dysfunction in women with bipolar disorder: The potential influence of family history of type 2 diabetes mellitus

Bipolar Disorders

Volumn 12, Issue 5, 2010, Pages 504-513

  Rasgon, Natalie L ^a   Kenna, Heather A ^a   Reynolds May, Margaret F ^a   Stemmle, Pascale G ^a   Vemuri, Mytilee ^a   Marsh, Wendy ^b   Wang, Po ^a   Ketter, Terence A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Family history of diabetes; Insulin resistance; Metabolic dysfunction; Obesity; Women

Indexed keywords

BIOLOGICAL MARKER; INSULIN; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; DISEASE SEVERITY; DRUG EXPOSURE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; WAIST CIRCUMFERENCE;

ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MULTIVARIATE ANALYSIS; OBESITY; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 77955592400     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00839.x     Document Type: Article

References (41)

1. Sachs GS. Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand Suppl 2004, 422:7-17.
2. Newcomer J. Metabolic syndrome and mental illness. Am J Manag Care 2007, 13:S170-S177.
3. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am 2008, 37:581-601.
4. Yaffe K. Metabolic syndrome and cognitive decline. Curr Alzheimer Res 2007, 4:123-126.
5. Rasgon NL, Altshuler LL, Fairbanks L. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005, 7:246-259.
6. Stemmle PG, Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL. Insulin resistance and hyperlipidemia in women with bipolar disorder. J Psychiatr Res 2009, 43:341-343.
7. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008, 10:607-616.
8. Cardenas J, Frye MA, Marusak SL. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106:91-97.
9. Garcia-Portilla M, Saiz P, Benabarre A. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106:197-201.
10. Fagiolini A, Frank E, Houck P. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002, 63:528-533.
11. Fagiolini A, Kupfer D, Houck P, Novick D, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003, 160:112-117.
12. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004, 53:495-499.
13. Gerich J. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003, 78:447-456.
14. Scollan-Koliopoulos M, O'Connell KA, Walker EA. The first diabetes educator is the family: using illness representation to recognize a multigenerational legacy of diabetes. Clin Nurse Spec 2005, 19:302-307.
15. Goldfine A, Bouche C, Parker R. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of diabetes. Proc Nat Acad Sci 2003, 100:2724-2729.
16. Balkau B, Lange C, Fezeu L. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008, 31:2056-2061.
17. Ghosh A, Liu T, Khoury MJ, Valdez R. Family history of diabetes and prevalence of the metabolic syndrome in U.S. adults without diabetes: 6-Year results from the National Health and Nutrition Examination Survey (1999-2004). Public Health Genomics 2009, 10.1159/000262330, doi
18. Rasgon N, Altshuler L, Gudeman D. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry 2000, 61:173-178.
19. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord 2003, 5:48-52.
20. Montgomery S, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
21. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978, 133:429-435.
22. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven G. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000, 23:171-175.
23. Kim S, Abbasi F, Reaven G. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004, 27:1998-2002.
24. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. Newcomer J. Antipsychotic medications; metabolic and cardiovascular risk. J Clin Psychiatry 2007, 68:8-13.
26. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
27. Elmslie JL, Silverstone JT, Mann JI, Williams SM, Romans SE. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000, 61:179-184.
28. Cassidy F, Ahearn E, Carroll B. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999, 156:1417-1420.
29. Goodwin F, Jamison K. Manic-Depressive Illness 1990, New York, NY, Oxford University Press
30. Keck P, McElroy S. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003, 64:1426-1435.
31. Masand P, Culpepper L, Henderson D. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS Spectr 2005, 10:1-15.
32. Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001, 62:486-491.
33. Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: A review. J Clin Psychiatry 2006, 67:1034-1041.
34. Maina G, Salvi V, Vitalucci A, D'Ambrosio V, Bogetto F. Prevalence and correlates of overweight in drug-naive patients with bipolar disorder. J Affect Disord 2008, 110:149-155.
35. Haupt D, Newcomer J. Abnormalities in glucose regulation associated with mental illness and treatment. J Psychosom Res 2002, 53:925-933.
36. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005 2005, Washington, DC, U.S. Department of Health and Human Services
37. Fleet-Michaliszyn SB, Soreca I, Otto AD. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects. J Clin Psychiatry 2008, 69:1892-1900.
38. Shen W, Punyanitya M, Chen J. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity 2006, 14:727-736.
39. Mitchell BD, Zaccaro D, Wagenknecht LE. Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study. Obes Res 2004, 12:831-839.
40. Nicklas BJ, Cesari M, Penninx BW. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 2006, 54:413-420.
41. McIntyre RS, Rasgon NL, Kemp DE. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009, 9:51-59.